Heidelberg Multimodal Animal Fundus Imaging Diagnostic Platform
Key words:
Classification:
- Product Description
-
Confocal laser imaging technology cSLo
Based on the confocal laser imaging principle, out-of-focus plane information is filtered out, and extremely clear imaging is achieved
Retinal automatic layering technology
Automatically identify the structure of each layer of the retina, up to 14 layers can be achieved, and subtle lesions can be accurately identified
Dual light source real-time eye tracking technology
TruTrack dual-light eye tracking technology eliminates eye movement artifacts and obtains high-resolution images
Automatic superposition noise reduction technology
Real-time automatic stacking noise reduction technology (ART) can achieve up to 100 B-scan stacking, greatly improving image contrast and showing the details of vitreous, retina and choroid at a glance
Follow-up
Automatically identify and locate the same fundus position to objectively evaluate disease progression and treatment effects
Continuous expansion and upgrading
More than ten imaging modules are available, and new modules can be upgraded on the original equipment to ensure data continuity and long-term follow-up
Animal Module
Based on the principle of confocal laser imaging, multiple imaging modes, small pupils can also be clearly imaged; equipped with a small animal 25D lens and adjustable reference arm length, it can realize the synchronous display of fundus and OCT images
HRA+OCT
Infinitely expandable multi-mode fundus imaging diagnostic platform, real-time joint scanning and "point-to-point" alignment analysis of at least six fundus imaging modes, providing more complete and accurate diagnostic information
Confocal Laser Synchronous Angiography System HRA
Based on the principle of confocal laser imaging technology, it can simultaneously perform retinal angiography and choroidal angiography, as well as various imaging modes such as autofluorescence and colorful imaging (optional). Various angle lenses (30°, 55°, 102° lenses (optional) are available for clinical and scientific research selection.
Bluepeak OCT
Fundus autofluorescence imaging combined with OCT scanning in real time to achieve an organic combination of fundus function assessment and structural diagnosis
0CT2
Scanning speed 85000A-scan/second, equipped with SPECTRALIS core and DNA, can obtain higher quality vitreous and choroidal images, shorten examination time, and make patients more comfortable; ideal platform for blood flow OCT and glaucoma GMPE modules
OCT
Scanning speed 40000A-scan/second, with SPECTRALIS core DNA
Retinal Microscopy HMM
8° fundus cSLO, comparable to adaptive optics in vivo cell-level imaging; non-invasive, direct, objective, integrated into the Heidelberg multimodal fundus imaging diagnostic platform; in the future, it can be used to widely observe visual cells, nerve fiber bundles, lamina cribrosa, etc., directly observe cell morphology, and evaluate follow-up effects
Blood flow OCT (OCTA)
Blood flow OCT that matches histological vascular stratification, 6um image resolution clearly displays retinal capillary details, full spectrum probability algorithm presents higher image contrast, SPT customized scanning system provides multi-modal imaging joint diagnosis solutions
Multicolor oCT
Multi-wavelength colorful laser fundus imaging provides richer diagnostic information than traditional fundus color photography, and real-time combined OCT scanning can achieve three-dimensional positioning diagnosis of fundus structure.
OPERA ophthalmology information platform
User list:
3 units in the laboratory of Zhongshan Ophthalmology Center of Sun Yat-sen University
Beijing Tongren Hospital Laboratory
Laboratory of Shanghai Fudan University Eye, Ear, Nose and Throat Hospital
Laboratory of Wenzhou Medical University Eye and Optometry Hospital
West China Hospital Ophthalmology Laboratory
Institute of Zoology, Chinese Academy of Sciences
Suzhou WuXi AppTec New Drug Development Co., Ltd.
Chengdu WuXi AppTec New Drug Development Company
Suzhou Zhaoyan New Drug Research Co., Ltd.
Chengdu Haiqi National Center for New Drug Safety Evaluation
Haimen Yinuo New Drug Safety Evaluation Center
Wuhan Neuforth Gene Therapy Eye Drug Development Company
Nanjing Dingtai New Drug Development Company
Kunming Keling Biotechnology Company
Shenyang Xingqi Eye Drug Company Laboratory
The First Affiliated Hospital of Harbin Medical University
The First Affiliated Hospital of China Medical University
Xuanwu Hospital Affiliated to Capital Medical University
Beijing Jishuitan Hospital (Huilongguan Campus)
The Second Hospital of Hebei Medical University
Tianjin First Central Hospital
Tianjin Medical University Eye Hospital
Fudan University Eye, Ear, Nose and Throat Hospital (Special Examination Department)
The First Affiliated Hospital of Guangzhou Medical University
Xiamen Eye Center
Xiamen University Affiliated Xiamen Eye Center
Shandong Academy of Pharmaceutical Sciences
Xi'an Fourth Hospital
The Hong Kong Polytechnic University
Product inquiry
Looking forward to your message ！
